Phaxiam enrols first patient in endocarditis infection study
Phaxiam Therapeutics has announced the enrolment of the first patient to a Phase I trial on the treatment of endocarditis…
Phaxiam Therapeutics has announced the enrolment of the first patient to a Phase I trial on the treatment of endocarditis…
First Ascent Biomedical has published the results of a clinical trial which utilised an AI-powered functional precision medicine (FPM) platform…